×

Treating hyperammonemia, reducing plasma ammonia with TLR4 antagonists

  • US 10,639,346 B2
  • Filed: 01/08/2018
  • Issued: 05/05/2020
  • Est. Priority Date: 08/17/2010
  • Status: Active Grant
First Claim
Patent Images

1. A method for reducing plasma ammonia in a patient comprising administering to the patient an effective amount of an antagonist of TLR4, wherein the TLR4 antagonist comprises TAK-242 or STM28.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×